end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccruedLiabilitiesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ConversionOfStockAmountConverted1,ConversionOfStockSharesIssued1,Depreciation,EarningsPerShareBasicAndDiluted,EmployeeRelatedLiabilitiesCurrent,FairValueAssetsLevel1ToLevel2TransfersAmount,FairValueAssetsLevel2ToLevel1TransfersAmount,GeneralAndAdministrativeExpense,ImpairmentOfLongLivedAssetsHeldForUse,IncomeLossFromContinuingOperationsPerBasicAndDilutedShare,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInEmployeeRelatedLiabilities,IncreaseDecreaseInOtherAccruedLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestIncomeOther,LeaseAndRentalExpense,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,MarketableSecurities,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NumberOfOperatingSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseExpense,OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear,OtherAccruedLiabilitiesCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,OtherComprehensiveIncomeLossNetOfTax,OtherLiabilitiesNoncurrent,OtherNonoperatingIncome,PaymentsOfStockIssuanceCosts,PaymentsToAcquireMarketableSecurities,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock,ProceedsFromSaleAndMaturityOfMarketableSecurities,ProceedsFromStockOptionsExercised,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,StockholdersEquity,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,TemporaryEquityCarryingAmountAttributableToParent,TemporaryEquityParOrStatedValuePerShare,TemporaryEquitySharesAuthorized,UnrecognizedTaxBenefits,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,DeferredTaxAssetsGross,DeferredTaxAssetsOperatingLossCarryforwardsDomestic,DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwardsResearch,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesPropertyPlantAndEquipment,DefinedContributionPlanEmployerDiscretionaryContributionAmount,EarningsPerShareBasic,EarningsPerShareDiluted,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCreditsResearch,IncomeLossFromContinuingOperationsPerBasicShare,IncomeLossFromContinuingOperationsPerDilutedShare,IncomeTaxExpenseBenefit,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,OperatingLossCarryforwards,PreferredStockDividendRatePercentage,ProceedsFromStockPlans,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan,ValuationAllowanceDeferredTaxAssetChangeInAmount,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfSharesOutstandingBasic
2021-03-31,2021-05-13,10-Q,"Edgewise Therapeutics,Â Inc.",EWTX,CIK0001710072,USD,1621000.0,2558000.0,509000.0,-54000.0,347405000.0,296000.0,296000.0,42533826.0,311245000.0,310545000.0,54700000.0,221036000.0,116120000.0,0.0001,1000000000.0,49254311.0,49254311.0,5000.0,-6869000.0,160214000.0,1.0,79000.0,-4.37,672000.0,0.0,0.0,1497000.0,0.0,-4.37,-63000.0,-503000.0,1015000.0,66000.0,42000.0,22000.0,,,311245000.0,4851000.0,88835000.0,186950000.0,-64773000.0,-6057000.0,-6815000.0,1.0,6857000.0,-6857000.0,,35000.0,260000.0,201000.0,-54000.0,-54000.0,,42000.0,124000.0,64711000.0,62000.0,0.0001,200000000.0,,0.0,674000.0,187051000.0,,,23000.0,-6815000.0,1008000.0,499000.0,5360000.0,-40962000.0,296000.0,306394000.0,160214000.0,186148000.0,25000.0,,0.0001,200000000.0,0.0,1559868.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-06-30,2021-08-09,10-Q,"Edgewise Therapeutics,Â Inc.",EWTX,CIK0001710072,USD,2816000.0,2550000.0,560000.0,-33000.0,348097000.0,687000.0,687000.0,7649179.0,303493000.0,302969000.0,135100000.0,50404000.0,,0.0001,1000000000.0,49261995.0,49261995.0,5000.0,-10332000.0,,,51000.0,-0.21,1373000.0,0.0,0.0,2599000.0,0.0,-0.21,,,,,107000.0,,13000.0,,303493000.0,6739000.0,248747000.0,,,,-10353000.0,,10460000.0,-10460000.0,22000.0,,243000.0,,21000.0,21000.0,,107000.0,,,,0.0001,200000000.0,0.0,0.0,3818000.0,,,,,,1084000.0,524000.0,7861000.0,-51315000.0,,296754000.0,,,5000.0,,0.0001,200000000.0,0.0,49258449.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-10,10-Q,"Edgewise Therapeutics,Â Inc.",EWTX,CIK0001710072,USD,2292000.0,4432000.0,624000.0,-24000.0,349682000.0,1548000.0,1548000.0,8517684.0,294448000.0,293242000.0,170100000.0,10571000.0,,0.0001,1000000000.0,49295840.0,49295840.0,5000.0,-12940000.0,,,64000.0,-0.26,2030000.0,0.0,0.0,3196000.0,0.0,-0.26,,,,,127000.0,,173000.0,9049000.0,294448000.0,8754000.0,279913000.0,,,,-12949000.0,,13076000.0,-13076000.0,22000.0,,361000.0,295000.0,9000.0,9000.0,295000.0,127000.0,,,,0.0001,200000000.0,0.0,0.0,2758000.0,,,,,,1535000.0,911000.0,9880000.0,-64264000.0,,285399000.0,,,37000.0,,0.0001,200000000.0,0.0,49264938.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-12-31,2022-02-24,10-K,"Edgewise Therapeutics,Â Inc.",EWTX,CIK0001710072,USD,3843000.0,3881000.0,702000.0,-514000.0,351852000.0,4404000.0,4404000.0,16863218.0,285233000.0,283773000.0,184800000.0,15566000.0,-89350000.0,0.0001,1000000000.0,49500308.0,49500308.0,5000.0,-43327000.0,160214000.0,1.0,272000.0,,2797000.0,0.0,0.0,11026000.0,0.0,,2654000.0,1622000.0,2746000.0,2392000.0,402000.0,,,10850000.0,285233000.0,10521000.0,265223000.0,186384000.0,-242227000.0,-33507000.0,-42813000.0,1.0,43215000.0,-43215000.0,110000.0,,411000.0,548000.0,-514000.0,-514000.0,329000.0,402000.0,124000.0,288203000.0,668000.0,0.0001,200000000.0,0.0,0.0,2984000.0,186148000.0,,43200000.0,112000.0,-42813000.0,1614000.0,912000.0,32189000.0,-76960000.0,4404000.0,274383000.0,160214000.0,186148000.0,116000.0,,,,0.0,,15566000.0,20530000.0,14570000.0,3187000.0,141000.0,1130000.0,771000.0,773000.0,20530000.0,42000.0,47000.0,-1.14,-1.14,0.21,-0.273,0.045,0.018,-1.14,-1.14,0.0,141000.0,69400000.0,0.08,248000.0,,248000.0,11700000.0,37526332.0,37526332.0
